Results 201 to 210 of about 65,232 (224)
Case Report: Personalized therapy in gynecological neuroendocrine neoplasm: a case of BRCA2-mutated ovarian neuroendocrine carcinoma treated with PARP-inhibitor. [PDF]
Mantiero M +8 more
europepmc +1 more source
Molecular architecture of the tumor microenvironment caused by <i>BRCA1</i> and <i>BRCA2</i> somatic mutations in human lung adenocarcinoma. [PDF]
Liao G +9 more
europepmc +1 more source
Breast and Ovarian Cancer Among Individuals Undergoing BRCA1 and BRCA2 Testing.
Dossa F +6 more
europepmc +1 more source
Comprehensive evidence for the pathogenicity of the <i>BRCA2</i> c.7847C>T (p.Ser2616Phe) variant specific to the Japanese population. [PDF]
Yamazawa K +33 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
DSS1 and ssDNA regulate oligomerization of BRCA2
Nucleic Acids Research, 2020Jie Liu, Wolf-Dietrich Heyer, Fei Guo
exaly
Architectural plasticity of human BRCA2–RAD51 complexes in DNA break repair
Nucleic Acids Research, 2017Roland Kanaar +2 more
exaly

